IRhythm Technologies Research and Development Expenses 2015-2025 | IRTC
IRhythm Technologies annual/quarterly research and development expenses history and growth rate from 2015 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
- IRhythm Technologies research and development expenses for the quarter ending June 30, 2025 were $0.023B, a 15.34% increase year-over-year.
- IRhythm Technologies research and development expenses for the twelve months ending June 30, 2025 were $0.112B, a 63.24% increase year-over-year.
- IRhythm Technologies annual research and development expenses for 2024 were $0.104B, a 72.35% increase from 2023.
- IRhythm Technologies annual research and development expenses for 2023 were $0.06B, a 29.25% increase from 2022.
- IRhythm Technologies annual research and development expenses for 2022 were $0.047B, a 20.53% increase from 2021.
| IRhythm Technologies Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $104 |
| 2023 | $60 |
| 2022 | $47 |
| 2021 | $39 |
| 2020 | $41 |
| 2019 | $37 |
| 2018 | $21 |
| 2017 | $13 |
| 2016 | $7 |
| 2015 | $6 |
| 2014 | $6 |
| IRhythm Technologies Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-06-30 | $23 |
| 2025-03-31 | $22 |
| 2024-12-31 | $19 |
| 2024-09-30 | $48 |
| 2024-06-30 | $20 |
| 2024-03-31 | $17 |
| 2023-12-31 | $15 |
| 2023-09-30 | $16 |
| 2023-06-30 | $14 |
| 2023-03-31 | $15 |
| 2022-12-31 | $13 |
| 2022-09-30 | $11 |
| 2022-06-30 | $12 |
| 2022-03-31 | $11 |
| 2021-12-31 | $12 |
| 2021-09-30 | $9 |
| 2021-06-30 | $10 |
| 2021-03-31 | $9 |
| 2020-12-31 | $12 |
| 2020-09-30 | $9 |
| 2020-06-30 | $13 |
| 2020-03-31 | $8 |
| 2019-12-31 | $9 |
| 2019-09-30 | $13 |
| 2019-06-30 | $8 |
| 2019-03-31 | $7 |
| 2018-12-31 | $7 |
| 2018-09-30 | $5 |
| 2018-06-30 | $5 |
| 2018-03-31 | $4 |
| 2017-12-31 | $4 |
| 2017-09-30 | $4 |
| 2017-06-30 | $3 |
| 2017-03-31 | $3 |
| 2016-12-31 | $2 |
| 2016-09-30 | $2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $2 |
| 2015-12-31 | |
| 2015-09-30 | $2 |
| 2015-06-30 | $0 |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.455B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.976B | 58.72 |
| Doximity (DOCS) | United States | $12.734B | 56.66 |
| Tempus AI (TEM) | United States | $12.722B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.947B | 81.50 |
| Hinge Health (HNGE) | United States | $4.531B | 0.00 |
| Heartflow (HTFL) | $2.821B | 0.00 | |
| Inspire Medical Systems (INSP) | United States | $2.730B | 40.13 |
| Privia Health (PRVA) | United States | $2.669B | 197.73 |
| Phreesia (PHR) | United States | $1.904B | 0.00 |
| Enovis (ENOV) | United States | $1.773B | 9.37 |
| 10x Genomics (TXG) | United States | $1.745B | 0.00 |
| Omnicell (OMCL) | United States | $1.526B | 29.41 |
| Schrodinger (SDGR) | United States | $1.457B | 0.00 |
| Azenta (AZTA) | United States | $1.384B | 60.40 |
| Clover Health Investments (CLOV) | United States | $1.379B | 0.00 |
| Claritev (CTEV) | United States | $1.184B | 0.00 |
| Evolent Health (EVH) | United States | $1.130B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.662B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.542B | 0.00 |
| Veradigm (MDRX) | United States | $0.535B | 0.00 |
| Standard BioTools (LAB) | United States | $0.489B | 0.00 |
| Talkspace (TALK) | United States | $0.454B | 135.50 |
| Butterfly Network (BFLY) | United States | $0.395B | 0.00 |
| Carlsmed (CARL) | United States | $0.369B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 52.95 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| Outset Medical (OM) | United States | $0.248B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.225B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.210B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| CapsoVision (CV) | United States | $0.185B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.157B | 7.13 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.085B | 0.00 |
| Pulmonx (LUNG) | United States | $0.076B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.040B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| PROFUSA (PFSA) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |